🇺🇸 FDA
Pipeline program

Oxycodone IN

2024-515461-34-00

Phase 1 small_molecule completed

Quick answer

Oxycodone IN for Physiologically Based Pharmacokinetic is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Physiologically Based Pharmacokinetic
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials